title: [Prevention, treatment and management of inflammation in atherosclerosis].
abstract: Incidence rate of arteriosclerotic disease such as ischemic heart disease and stroke has been on the rise in Japan due to the westernized dietary habit, insufficient exercise brought about by persistent motorization and increase in mental stress caused by social downturn as well as rapid progression of aging society. In this paper, we'll outline prevention, treatment and control of arteriosclerosis from a perspective of antiinflammation.
authors.affiliation: Clinical Cell Biology and Internal Medicine, Graduate School of Medicine, Chiba University.
authors.forename: Minoru
authors.initials: M
authors.lastname: Takemoto
authors.forename: Koutaro
authors.initials: K
authors.lastname: Yokote
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D050197:Atherosclerosis / Q000209:etiology* / Q000517:prevention & control / Q000628:therapy; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis; D002908:Chronic Disease; D004038:Diet, Reducing; D006710:Homocysteine / Q000097:blood; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007249:Inflammation / Q000150:complications* / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D007674:Kidney Diseases; D017270:Lipoprotein(a); D008077:Lipoproteins, LDL; D024821:Metabolic Syndrome; D018384:Oxidative Stress; D000077205:Pioglitazone; D012307:Risk Factors; D016540:Smoking Cessation; D045162:Thiazolidinediones / Q000627:therapeutic use
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D015415:Biomarkers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D017270:Lipoprotein(a); D008077:Lipoproteins, LDL; D045162:Thiazolidinediones; C099252:oxidized low density lipoprotein; D006710:Homocysteine; D002097:C-Reactive Protein; D000077205:Pioglitazone